Biofrontera Inc. Accounts Receivable, Related Parties, Noncurrent
Biofrontera Inc. (BFRI) had Accounts Receivable, Related Parties, Noncurrent of $2.81 million as of 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued › Notes › Receivables
us-gaap:AccountsReceivableRelatedPartiesNoncurrent · last filed 2023-03-13
- 2022-12-31: Accounts Receivable, Related Parties, Noncurrent $2.81M.
- 2022-09-30: Accounts Receivable, Related Parties, Noncurrent $2.81M.
- 2022-06-30: Accounts Receivable, Related Parties, Noncurrent $2.81M.
- 2022-03-31: Accounts Receivable, Related Parties, Noncurrent $2.81M.
| Period end | Accounts Receivable, Related Parties, Noncurrent |
|---|---|
| 2022-12-31 | $2.81M 10-K · filed 2023-03-13 |
| 2022-09-30 | $2.81M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.81M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $2.81M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $2.81M 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |